特變電工(600089.SH):準東一期10萬噸/年多晶硅項目預計於2023年四季度投達產
格隆匯8月9日丨有投資者向特變電工(600089.SH)提問,“請問公司準東10萬噸多晶硅項目何時投產?目前多晶硅價格情況下,二期項目是否會很快啟動建設?”,公司回覆稱,公司準東一期10萬噸/年多晶硅項目於2023年中期分產線開展設備調試、試生產工作,預計於2023年四季度投達產。準東多晶硅項目是新特能源A股IPO的募投項目,公司會根據準東一期投產及新特能源A股IPO募集資金到位情況確定二期項目的建設進度。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.